Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HK1 | P19367 | 1/20 | 0.35 |
| ▸ | HK2 | P52789 | 1/20 | 0.35 |
| ▸ | GBA1 | P04062 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | GRK6 | P43250 | 2/20 | 0.35 |
| ▸ | MANBA | O00462 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | ADK | P55263 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.33 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9651142 | 0.71 | LMNA (0.36) | GBA1LMNAALDH1A1 | |
| SCHEMBL22698185 | 0.71 | LMNA (0.36) | GBA1LMNAALDH1A1 | |
| SCHEMBL13227665 | 0.71 | LMNA (0.36) | GBA1LMNAALDH1A1 | |
| SCHEMBL26878955 | 0.69 | LMNA (0.35) | GBA1LMNA | |
| SCHEMBL26651247 | 0.66 | OGA (0.33) | GBA1LMNA | |
| SCHEMBL25867417 | 0.66 | OGA (0.33) | GBA1LMNA | |
| SCHEMBL14426674 | 0.65 | OGA (0.36) | GBA1LMNA | |
| SCHEMBL13065550 | 0.65 | — | — | |
| SCHEMBL4235182 | 0.64 | GRK6 (0.32) | HK1HK2GRK6CYP1A2NFKB1 | |
| SCHEMBL4386759 | 0.63 | GPR35 (0.46) | LMNAGRK6CYP1A2NFKB1THPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115433243-B | Method for synthesizing 1,1' -thiodisaccharide with high stereoselectivity by organic catalysis | 江西师范大学 | 2025-03-25 | — | — | CN | disclosed |
| CN-115433243-A | Method for synthesizing 1,1' -thiodisaccharide with high stereoselectivity by organic catalysis | 江西师范大学 | 2022-12-06 | — | — | CN | disclosed |
| US-7078520-B2 | Glycosylation of exo-glycals | ACADEMIA SINICA (TW) | 2006-07-18 | — | — | US | disclosed |
| US-20040199029-A1 | Glycosylation of exo-glycals | ACADEMIA SINICA (TW) | 2004-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040199029-A1 | Glycosylation of exo-glycals | ST6GAL1, GNE, GALE | HK1 909/4885HK2 919/4885GBA1 94/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.